Simplex Trading’s Perspective Therapeutics CATX Stock Holding History

Simplex Trading’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$230K	Buy	+55,200	New	+$233K	﹤0.01%	4137
2025 Q4	–	Sell	-7,900	Closed	-$27K	–	8657
2025 Q3	$27K	Buy	7,900 +4,300	+119%	+$15.7K	﹤0.01%	7057
2025 Q2	$12K	Sell	3,600 -17,100	-83%	-$45.1K	﹤0.01%	7157
2025 Q1	$44K	Buy	20,700 +500	+2%	+$1.5K	﹤0.01%	5892
2024 Q4	$64K	Buy	+20,200	New	+$165K	﹤0.01%	5610

Other funds holding CATX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's CATX Position: Q1 2026 in Review

Simplex Trading opened a new position in Perspective Therapeutics (CATX) in Q1 2026: 42,486 shares worth $177K. The stake represents ﹤0.01% of the portfolio and ranks #4435 among its holdings.

138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

Simplex Trading held 42,486 shares of Perspective Therapeutics worth $177K as of Q1 2026.
Perspective Therapeutics was a new Simplex Trading position in Q1 2026.
Perspective Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4435 holding.
138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.